CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity

Antiviral Research

Volumn 39, Issue 3, 1998, Pages 175-187

  Schols, Dominique ^a   Proost, Paul ^a   Struyf, Sofie ^a   Wuyts, Anja ^a   De Meester, Ingrid ^b   Scharpé, Simon ^b   Van Damme, Jo ^a   De Clercq, Erik ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Anti HIV 1 activity; CCR5; CD26; RANTES

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; RANTES;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN PROCESSING; VIRUS REPLICATION;

ANTIGENS, CD26; BINDING, COMPETITIVE; CALCIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; RANTES; RECEPTORS, CCR5; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 17044448314     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(98)00039-4     Document Type: Article

References (52)

1. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1996;1955-1958.
2. Arenzana-Seisdedos F., Virelizier J.-L., Rousset D., Clark-Lewis I., Loetscher P., Moser B., Baggiolini M. HIV blocked by chemokine antagonist. Nature. 383:1996;400.
3. Atchison R.E., Gosling J., Monteclaro F.S., Franci C., Digilio L., Charo I.F., Goldsmith M.A. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science. 274:1996;1924-1926.
4. Ben-Baruch A., Bengali K.M., Biragyn A.et al. Interleukin-8 receptor β. The role of the carboxyl terminus in signal transduction. J. Biol. Chem. 270:1995;9121-9128.
5. Berson J.F., Long D., Doranz B.J., Rucker J., Jirik F.R., Doms R.W. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type-1 strains. J. Virol. 70:1996;6288-6295.
6. Bieniasz P.D., Fridell R.A., Aramori I., Ferguson S.S.G., Caron M.G., Cullen B.R. HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor. EMBO J. 16:1997;2599-2609.
7. Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T.A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 382:1996;829-832.
8. Bleul C.C., Wu L., Hoxie J.A., Springer T.A., Mackay C.R. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA. 94:1997;1925-1930.
9. + T cells. Science. 262:1993;2045-2050.
10. Choe H., Farzan M., Sun Y.et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1996;1135-1148.
11. + T cells. Science. 270:1995;1811-1815.
12. Connor R.I., Sheridan K.E., Ceradini D., Choe S., Landau N.R. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J. Exp. Med. 185:1997;621-628.
13. De Meester I., Vanhoof G., Lambeir A.-M., Scharpé S. Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5). J. Immunol. Methods. 189:1996;99-105.
14. Dean, M., Carrington, M., Winkler, C. et al., Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study, O'Brien, S.J., 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273, 1856-1862.
15. Deng H., Liu R., Ellmeier W.et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
16. Deng H., Unutmaz D., KewalRamani V.N., Littman D.R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature. 388:1997;296-300.
17. Doranz B.J., Rucker J., Yi Y.et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1996;1149-1158.
18. + cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
19. Edinger A.L., Amedee A., Miller K.et al. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc. Natl. Acad. Sci. USA. 94:1997;4005-4010.
20. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:1996;872-877.
21. Gosling J., Monteclaro F.S., Atchison R.E., Arai H., Tsou C.-L., Goldsmith M.A., Charo I.F. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. USA. 94:1997;5061-5066.
22. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
23. Lambeir A.-M., Diaz-Peirera J.F., Chacon P.et al. A prediction of DPP IV/CD26 domain structure from a physico-chemical investigation of dipeptidyl peptidase IV (CD26) from human seminal plasma. Biochim. Biophys. Acta. 1340:1997;215-226.
24. Liu R., Paxton W.A., Choe S.et al. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:1996;367-377.
25. Naif H.M., Li S., Ho-Shon M., Mathijs J.-M., Williamson P., Cunningham A.L. The state of maturation of monocytes into macrophages determines the effects of IL-4 and IL-13 on HIV replication. J. Immunol. 158:1997;501-511.
26. Oberlin E., Amara A., Bachelerie F.et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 382:1996;833-835.
27. Oravecz T., Roderiquez G., Koffi J.et al. CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV-1 strains in a T-cell line. Nature Med. 1:1995;919-926.
28. Oravecz T., Pall M., Roderiquez G.et al. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186:1997;1865-1872.
29. Pakianathan D.R., Kuta E.G., Artis D.R., Skelton N.J., Hébert C.A. Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3, and CCR5. Biochemistry. 36:1997;9642-9648.
30. Picard L., Simmons G., Power C.A., Meyer A., Weiss R.A., Clapham P.R. Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. J. Virol. 71:1997;5003-5011.
31. Proost P., De Meester I., Schols D.et al. Amino-terminal truncation of chemokines by CD26/dipeptidyl peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1 infections. J. Biol. Chem. 27:1998;7222-7227.
32. Proost P., Struyf S., Couvreur M.et al. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2 (6-76) as a natural chemokine inhibitor. J. Immunol. 160:1998;4034-4041.
33. Quillent C., Oberlin E., Braun J.et al. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet. 351:1998;14-18.
34. Rucker J., Samson M., Doranz B.J.et al. Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell. 87:1996;437-446.
35. Samson M., Libert F., Doranz B.J.et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382:1996;722-725.
36. Samson M., LaRosa G., Libert F., Paindlavoine P., Detheux M., Vassart G., Parmentier M. The second extracellular loop of CCR5 is the major determinant of ligand specificity. J. Biol. Chem. 272:1997;24934-24941.
37. Schmidtmayerova H., Sherry B., Bukrinsky M. Chemokines and HIV replication. Nature. 382:1996;767.
38. + memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc. Natl. Acad. Sci. USA. 87:1990;6058-6062.
39. Schols D., Proost P., Van Damme J., De Clercq E. RANTES and MCP-3 inhibit the replication of T-cell-tropic human immunodeficiency virus type 1 strains (SF-2, MN, and HE). J. Virol. 71:1997;7300-7304.
40. Schols D., Struyf S., Van Damme J., Esté J.A., Henson G., De Clercq E. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J. Exp. Med. 186:1997;1383-1388.
41. Simmons G., Clapham P.R., Picard L.et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science. 276:1997;276-279.
42. Struyf S., De Meester I., Scharpé S., Lenaerts J.P., Menten P., Proost P., Van Damme J. Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor. Eur. J. Immunol. 28:1998;1262-1271.
43. Tanaka T., Duke-Cohan J.S., Kameoka J., Yaron A., Lee I., Schlossman S.F., Morimoto C. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc. Natl. Acad. Sci. USA. 91:1994;3082-3086.
44. Trkola A., Dragic T., Arthos J.et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature. 384:1996;184-187.
45. 2-terminally processed forms. Eur. J. Immunol. 20:1990;2113-2118.
46. + T lymphocytes of HIV-infected subjects. J. Acquired Immune Defic. Syndr. 6:1993;749-757.
47. Vanhoof G., De Meester I., Van Sande M., Scharpé S., Yaron A. Distribution of proline-specific aminopeptidases in human tissues and body fluids. Eur. J. Clin. Chem. Clin. Biochem. 30:1992;333-338.
48. Verani A., Scarlatti G., Comar M.et al. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J. Exp. Med. 185:1997;805-816.
49. Walter R., Simmons W.H., Yoshimoto T. Proline specific endo- and exopeptidase. Mol. Cell. Biochem. 30:1980;111-127.
50. Wu L., Gerard N.P., Wyatt R.et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature. 384:1996;179-183.
51. Wu L., Paxton W.A., Kassam N.et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J. Exp. Med. 185:1997;1681-1691.
52. Wuyts A., Van Osselaer N., Haelens A.et al. Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry. 36:1997;2716-2723.